Premesis Chewable Tablet is primarily indicated in conditions like Moderately emetognic chemotherapy or radiotherapy, Nausea and vomiting (chemotherapy induced), Post operative vomiting, Post-operative nausea, Post-operative nausea and vomiting, Prevention of post-operative nausea and vomiting, Severely emetognic chemotherapy.
Premesis Chewable Tablet is contraindicated in conditions like Hypersensitivity.
The severe or irreversible adverse effects of Premesis Chewable Tablet(HCI), which give rise to further complications include Cardiac arrhythmias, Bronchospasm, Cardiac arrhythmias, Bradycardia, Bronchospasm, Angioedema, Angina, Angioedema, Hyperbilirubinemia. The symptomatic adverse reactions produced by Premesis Chewable Tablet(HCI) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Fever, Dyspnea, Constipation, Abdominal pain, Chills, Hypotension, Flushing, Hiccups, Xerostomia, Vision disturbances, Reaction at injection site, Warmth sensation, dizziness, Hypotension.
Dosage restriction is advisable in patients with moderate to severe liver impairment. Ondansetron should be used with caution during pregnancy or lactation. Care is required in the patient exhibiting hypersensitivity to other selective 5HT3 receptor antagonists and in patient with signs of subacute intestinal obstruction.